Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Mylan Labs
Mylan Labs
Amgen's $3.9B Neulasta to face U.S. biosim 'in the coming weeks' with Mylan approval
Fierce Pharma
Tue, 06/5/18 - 12:02 pm
FDA
Fulphila
Mylan Labs
biosimilars
Amgen
Neulasta
Instead of 'curling up in a corner,' Mylan CEO says, she used EpiPen to fight flawed pricing
Fierce Pharma
Mon, 06/4/18 - 10:01 pm
Mylan Labs
EpiPens
Heather Bresch
drug pricing
Pfizer lies behind Mylan’s issues with Epipen
GoinPharma
Mon, 05/28/18 - 01:29 pm
Mylan Labs
EpiPens
drug shortage
Pfizer
FDA Denies Mylan Petition on Advair Generics
RAPS.org
Thu, 05/10/18 - 11:04 pm
FDA
Mylan Labs
generics
Advair
Mylan Faces EpiPen Shortage as Slowing Sales Trip Up Its Results
Bloomberg
Wed, 05/9/18 - 11:27 am
Mylan Labs
earnings
EpiPens
A contentious West Virginia Senate race pits two candidates with close ties to pharma
Stat
Wed, 05/9/18 - 11:08 am
West Virginia
Senate
Mylan Labs
Cardinal Health
lobbyists
politics
EpiPen shortages seen in Canada, UK but U.S. supply intact
Yahoo/Reuters
Sat, 04/14/18 - 01:23 pm
Mylan Labs
EpiPen
United States
Canada
Great Britain
drug shortages
Merck KGaA Consumer Unit Is a Deal Too Far for Mylan: Gadfly
Washington Post, DC
Sat, 04/14/18 - 12:34 pm
Merck KGaA
consumer health
M&A
Mylan Labs
Mylan seeks deal for German Merck's consumer products unit - sources
Yahoo/Reuters
Fri, 04/13/18 - 08:49 am
Mylan Labs
Merck KGaA
consumer health
M&A
Mylan and Mapi Pharma Partner on Once Monthly Glatiramer Acetate Drug for Relapsing-Remitting MS
CP Wire
Tue, 04/10/18 - 11:24 am
Mylan Labs
Mapi Pharma
GA Depot
MS
Relapsing Remitting Multiple Sclerosis
Botox Biosimilar in Development by Mylan and Revance Therapeutics
Xtalks
Mon, 03/5/18 - 11:10 am
Botox
Allergan
biosimilars
Mylan Labs
Revance Therapeutics
Mylan teams up with Revance on biosimilar for Botox
Reuters
Thu, 03/1/18 - 11:53 pm
Mylan Labs
ReVance
biosimilars
Botox
Mylan: Generic competition pushes EpiPen sales down
Drug Delivery Business News
Thu, 03/1/18 - 10:07 am
Mylan Labs
earnings
generics
EpiPens
Will Teva Pharmaceutical's Pain Be Mylan's Gain?
Motley Fool
Fri, 02/9/18 - 09:33 am
Teva Pharmaceutical
Mylan Labs
Copaxone
generics
MS
multiple sclerosis
Pfizer's EpiPen woes creep into Canada
Biopharma Dive
Fri, 01/26/18 - 09:04 am
Pfizer
Mylan Labs
EpiPens
Canada
drug shortages
Look out, Teva: Mylan's Copaxone copy has already captured serious share
Fierce Pharma
Thu, 01/4/18 - 10:10 pm
Teva Pharmaceutical
Mylan Labs
Copaxone
generics
MS
multiple sclerosis
Mylan, Momenta take aim at Regeneron’s Eylea with biosimilar
Drug Delivery Business News
Thu, 01/4/18 - 11:01 am
Mylan Labs
Momenta Pharmaceuticals
Regeneron
Eylea
biosimilars
diabetic macular edema
wet age-related macular degeneration
M710
Not Just Mylan: Misclassifications May Have Cost Medicaid More Than $1B
RAPS.org
Wed, 12/20/17 - 11:03 pm
Mylan Labs
Medicaid
HHS
OIG
Mylan Announces IPR Proceedings for Sanofi's Lantus Patents
Yahoo/Zacks.com
Fri, 12/15/17 - 11:45 pm
Mylan Labs
inter partes review
Sanofi
Lantus
patents
diabetes
Amazon in talks with generic drugmakers including Mylan, Sandoz about pharma play: report
Fierce Pharma
Sun, 12/3/17 - 11:35 am
Amazon
generics
Sandoz
Mylan Labs
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »